These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39095792)

  • 41. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer.
    Shimazu K; Tamaki Y; Taguchi T; Takamura Y; Noguchi S
    Surgery; 2002 Mar; 131(3):277-86. PubMed ID: 11894032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study.
    Somashekhar SP; Kumar CR; Ashwin KR; Zaveri SS; Jampani A; Ramya Y; Parameswaran R; Rakshit S
    Clin Breast Cancer; 2020 Oct; 20(5):e576-e583. PubMed ID: 32389561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Interest of periareolar injection for colorimetric detection of sentinel node in breast cancer].
    Mignotte H; Treilleux I; Chassagne-Clément C; Bem C; Lopez R; Martin X; Brémond A
    Bull Cancer; 2000 Jul; 87(7-8):600-3. PubMed ID: 10969216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer.
    Montgomery LL; Thorne AC; Van Zee KJ; Fey J; Heerdt AS; Gemignani M; Port E; Petrek J; Cody HS; Borgen PI
    Anesth Analg; 2002 Aug; 95(2):385-8, table of contents. PubMed ID: 12145056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeat Sentinel Lymph Node Surgery in Recurrent Breast Cancer: Peritumoral vs. Periareolar Injections.
    Guru SD; Hoskin TL; Whaley DH; Nathan MA; Jakub JW
    Clin Breast Cancer; 2021 Oct; 21(5):466-476. PubMed ID: 33736936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures.
    Cody HS; Fey J; Akhurst T; Fazzari M; Mazumdar M; Yeung H; Yeh SD; Borgen PI
    Ann Surg Oncol; 2001; 8(1):13-9. PubMed ID: 11206218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group.
    Martin RC; Edwards MJ; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Noyes RD; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Cerrito PB; McMasters KM
    Surgery; 2000 Aug; 128(2):139-44. PubMed ID: 10922983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic sentinel node and occult lesion localization in breast cancer (MagSNOLL Trial).
    Ahmed M; Anninga B; Goyal S; Young P; Pankhurst QA; Douek M;
    Br J Surg; 2015 May; 102(6):646-52. PubMed ID: 25868072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
    Han SN; Amant F; Cardonick EH; Loibl S; Peccatori FA; Gheysens O; Sangalli CA; Nekljudova V; Steffensen KD; Mhallem Gziri M; Schröder CP; Lok CAR; Verest A; Neven P; Smeets A; Pruneri G; Cremonesi M; Gentilini O;
    Breast Cancer Res Treat; 2018 Apr; 168(2):551-557. PubMed ID: 29235045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer.
    Guo W; Zhang L; Ji J; Gao W; Liu J; Tong M
    World J Surg Oncol; 2014 Sep; 12():290. PubMed ID: 25239029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A validation trial of subdermal injection compared with intraparenchymal injection for sentinel lymph node biopsy in breast cancer.
    Vargas HI; Tolmos J; Agbunag RV; Mishkin F; Vargas MP; Diggles L; Gonzalez KD; Venegas R; Klein SR; Khalkhali I
    Am Surg; 2002 Jan; 68(1):87-91. PubMed ID: 12467326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.
    Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ
    Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome of sentinel lymph node biopsy in breast cancer using dye alone: a single center review with a median follow-up of 5 years.
    Ogawa Y; Ikeda K; Ogisawa K; Tokunaga S; Fukushima H; Inoue T; Mori Y; Tachimori A; Inoue T; Nishiguchi Y
    Surg Today; 2014 Sep; 44(9):1633-7. PubMed ID: 24072399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Touch imprint cytology evaluation of sentinel lymph node in breast cancer.
    Khanna R; Bhadani S; Khanna S; Pandey M; Kumar M
    World J Surg; 2011 Jun; 35(6):1254-9. PubMed ID: 21487846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concordance between peri-areolar blue dye and peri-incisional radiotracer injections for sentinel node mapping in patients with a history of primary breast cancer excisonal biopsy.
    Mehrabibahar M; Azizi S; Jangjoo A; Saremi E; Kakhki VR; Sadeghi R; Chicken DW; Keshtgar M
    Acta Chir Belg; 2014; 114(1):31-3. PubMed ID: 24720135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
    Alvarado MD; Mittendorf EA; Teshome M; Thompson AM; Bold RJ; Gittleman MA; Beitsch PD; Blair SL; Kivilaid K; Harmer QJ; Hunt KK
    Ann Surg Oncol; 2019 Oct; 26(11):3510-3516. PubMed ID: 31297674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preliminary study of contrast-enhanced ultrasound in combination with blue dye vs. indocyanine green fluorescence, in combination with blue dye for sentinel lymph node biopsy in breast cancer.
    Zhou Y; Li Y; Mao F; Zhang J; Zhu Q; Shen S; Lin Y; Zhang X; Liu H; Xiao M; Jiang Y; Sun Q
    BMC Cancer; 2019 Oct; 19(1):939. PubMed ID: 31604469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Periareolar or Peritumoral Injection of Isosulfan Blue and the Effect on the Number of Sentinel Lymph Nodes Examined.
    Weber JJ; Wong JH
    Am Surg; 2017 Jan; 83(1):98-102. PubMed ID: 28234133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
    Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.